Cryo‐X‐Ray Phase Contrast Imaging Enables Combined 3D Structural Quantification and Nucleic Acid Analysis of Myocardial Biopsies
Source abstract
Abstract
Abstract Snap‐frozen biopsies serve as a valuable clinical resource of archival material for disease research, as they enable a comprehensive array of downstream analyses to be performed, including extraction and sequencing of nucleic acids. Obtaining three‐dimensional (3D) structural information before multi‐omics is more challenging but can potentially allow for better characterization of tissues and targeting of clinically relevant cells. Conventional histological techniques are limited in this regard due to their destructive nature and the reconstruction artifacts produced by sectioning, dehydration, and chemical processing. These limitations are particularly notable in soft tissues such as the heart. In this study, the feasibility of using synchrotron‐based cryo‐X‐ray phase contrast imaging (cryo‐X‐PCI) of snap‐frozen myocardial biopsies is assessed and 3D structure tensor analysis of aggregated myocytes, followed by nucleic acid (DNA and RNA) extraction and analysis. It is shown that optimal sample preparation is the key driver for successful structural and nucleic acid preservation which is unaffected by the process of cryo‐X‐PCI. It is proposed that cryo‐X‐PCI has clinical value for 3D tissue analysis of cardiac and potentially non‐cardiac soft tissue biopsies before nucleic acid investigation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced X-ray Imaging Techniques · Advanced Electron Microscopy Techniques and Applications · X-ray Spectroscopy and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Cardiovascular Science University College London London WC1N 1DZ UK
Paul Scherrer Institut Villigen 5232 Switzerland
Department of Cardiology St Bartholomew's Hospital London EC1A 7BE UK
European Synchrotron Radiation Facility 71 Av des Martyrs Grenoble 3800 France
Funding
British Heart Foundation · Chan Zuckerberg Initiative
References (52)
Show source-provided references
1. 10.1016/S0828-282X(09)70485-410.1016/S0828-282X(09)70485-4 ↗
2. 10.1038/s41467-022-32041-510.1038/s41467-022-32041-5 ↗
3. 10.1159/00052552310.1159/000525523 ↗
4. Meecham A. · Histochem. Cell Biol. · 2021 · 156 · 595
5. 10.1093/annonc/mdv61310.1093/annonc/mdv613 ↗
6. 10.1186/1755-8794-7-2310.1186/1755-8794-7-23 ↗
7. 10.1016/j.jmoldx.2013.05.00410.1016/j.jmoldx.2013.05.004 ↗
8. 10.1371/journal.pone.012681710.1371/journal.pone.0126817 ↗
9. 10.1038/s41598-016-0001-810.1038/s41598-016-0001-8 ↗
10. 10.1016/j.pbiomolbio.2021.07.00310.1016/j.pbiomolbio.2021.07.003 ↗
11. 10.1093/ehjci/jew31410.1093/ehjci/jew314 ↗
12. 10.1038/s41598-020-76809-510.1038/s41598-020-76809-5 ↗
13. 10.1038/s41598-017-03818-210.1038/s41598-017-03818-2 ↗
14. 10.1038/s41598-019-43407-z10.1038/s41598-019-43407-z ↗
15. 10.1364/BOE.38657610.1364/BOE.386576 ↗
16. 10.1093/gigascience/gix02710.1093/gigascience/gix027 ↗
17. 10.1016/j.heares.2019.10780610.1016/j.heares.2019.107806 ↗
18. 10.1038/s42003-023-04536-410.1038/s42003-023-04536-4 ↗
19. 10.1007/s13534-019-00122-y10.1007/s13534-019-00122-y ↗
20. 10.1117/1.JMI.7.2.02350110.1117/1.JMI.7.2.023501 ↗
21. 10.1371/journal.pone.012623010.1371/journal.pone.0126230 ↗
22. 10.1098/rsos.21106710.1098/rsos.211067 ↗
23. 10.1107/S160057752001132710.1107/S1600577520011327 ↗
24. 10.1038/s41598-021-93054-610.1038/s41598-021-93054-6 ↗
25. 10.1007/s00418-023-02220-610.1007/s00418-023-02220-6 ↗
26. 10.7554/eLife.6040810.7554/eLife.60408 ↗
27. 10.1371/journal.pone.028315910.1371/journal.pone.0283159 ↗
28. 10.1369/002215542094505010.1369/0022155420945050 ↗
29. 10.3390/biomedicines1012305410.3390/biomedicines10123054 ↗
30. 10.1002/pmic.20110055010.1002/pmic.201100550 ↗
31. Planinc I. · J. Heart Lung Transplant. · 2021 · 36
32. 10.1152/ajplung.00103.201910.1152/ajplung.00103.2019 ↗
33. 10.7554/eLife.7135910.7554/eLife.71359 ↗
34. 10.1007/978-3-319-59448-4_310.1007/978-3-319-59448-4_3 ↗
35. 10.1093/molbev/msw13910.1093/molbev/msw139 ↗
36. 10.1016/j.ymeth.2017.08.00210.1016/j.ymeth.2017.08.002 ↗
37. 10.1186/s12864-021-07744-610.1186/s12864-021-07744-6 ↗
38. 10.1016/j.joca.2022.06.00310.1016/j.joca.2022.06.003 ↗
39. 10.1038/s41467-022-34048-410.1038/s41467-022-34048-4 ↗
40. 10.1107/S090904951203286410.1107/S0909049512032864 ↗
41. 10.1046/j.1365-2818.2002.01010.x10.1046/j.1365-2818.2002.01010.x ↗
42. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
43. 10.1007/978-3-319-20309-6_1310.1007/978-3-319-20309-6_13 ↗
44. 10.1161/CIRCIMAGING.118.00775310.1161/CIRCIMAGING.118.007753 ↗
45. 10.1111/joa.1305810.1111/joa.13058 ↗
46. 10.3389/fcell.2022.100068410.3389/fcell.2022.1000684 ↗
47. Dejea H. · 2021
48. 10.1038/s41592-019-0582-910.1038/s41592-019-0582-9 ↗
49. N.Kong W.Ng L.Cai A.Leonardo B. C.Weimer 2016 100K Pathogen Genome Project.
50. 10.1186/1532-429X-14-7010.1186/1532-429X-14-70 ↗
51. 10.1038/s41598-023-35854-610.1038/s41598-023-35854-6 ↗
52. 10.1364/OE.41417410.1364/OE.414174 ↗